Skip to content
Open access · CC-BY via OpenAlex

Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival

Aurore Pire, Théo Z. Hirsch, Guillaume Morcrette, Sandrine Imbeaud, Barkha Gupta, Jill Pilet, Marianna Cornet, Monique Fabrè, Catherine Guettier, Sophie Branchereau, Laurence Brugières, Florent Guérin, Véronique Laithier, Carole Coze, Genta Nagae

European Journal of Cancer · 2024 · ▲ 18 citations

Abstract

BACKGROUND: Hepatoblastoma is the most frequent pediatric liver cancer. The current treatments lead to 80% of survival rate at 5 years. In this study, we evaluated the clinical relevance of molecular features to identify patients at risk of chemoresistance, relapse and death of disease. METHODS: All the clinical data of 86 children with hepatoblastoma were retrospectively collected. Pathological slides were reviewed, tumor DNA sequencing (by whole exome, whole genome or target) and transcriptomic profiling with RNAseq or 300-genes panel were performed. Associations between the clinical, pathological, mutational and transcriptomic data were investigated. RESULTS: High-risk patients represented 44% of our series and the median age at diagnosis was 21.9 months (range: 0-208). Alterations of the WNT/ß-catenin pathway and of the 11p15.5 imprinted locus were identified in 98% and 74% of the tumors, respectively. Other cancer driver genes mutations were only found in less than 11% of tumors. After neoadjuvant chemotherapy, disease-specific survival and poor response to neoadjuvant chemotherapy were associated with 'Liver Progenitor' (p = 0.00049, p < 0.0001) and 'Immune Cold' (p = 0.0011, p < 0.0001) transcriptomic tumor subtypes, SBS35 cisplatin mutational signature (p = 0.018, p = 0.001), mutations in rare cancer driver genes (p = 0.0039, p = 0.0017) and embryonal predominant histological type (p = 0.0013, p = 0.0077), respectively. Integration of the clinical and molecular features revealed a cluster of molecular markers associated with resistance to chemotherapy and survival, enlightening transcriptomic 'Immune Cold' and Liver Progenitor' as a predictor of survival independent of the clinical features. CONCLUSIONS: Response to neoadjuvant chemotherapy and survival in children treated for hepatoblastoma are associated with genomic and pathological features independently of the clinical features.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.ejca.2024.113583
Canonical
link ↗
Fetched
2026-11-16 MST

Cite this

APA
Pire, A., Hirsch, T.Z., Morcrette, G., Imbeaud, S., Gupta, B., Pilet, J., Cornet, M., Fabrè, M., Guettier, C., Branchereau, S., Brugières, L., Guérin, F., Laithier, V., Coze, C., Nagae, G., Hiyama, E., Laurent‐Puig, P., Rebouissou, S., Sarnacki, S., &amp; Chardot, C. (2024). Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival. <em>European Journal of Cancer</em>. https://doi.org/10.1016/j.ejca.2024.113583
Vancouver
Pire A, Hirsch TZ, Morcrette G, Imbeaud S, Gupta B, Pilet J, et al. Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2024.113583.
BibTeX
@article{aurore2024Mutati, title = {Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival}, author = {Aurore Pire and Théo Z. Hirsch and Guillaume Morcrette and Sandrine Imbeaud and Barkha Gupta and Jill Pilet and Marianna Cornet and Monique Fabrè and Catherine Guettier and Sophie Branchereau and Laurence Brugières and Florent Guérin and Véronique Laithier and Carole Coze and Genta Nagae and Eiso Hiyama and Pierre Laurent‐Puig and Sandra Rebouissou and Sabine Sarnacki and Christophe Chardot and Carmen Capito and Cécile Faure‐Conter and Isabelle Aerts and Sophie Taque and Brice C. Fresneau}, journal = {European Journal of Cancer}, year = {2024}, doi = {10.1016/j.ejca.2024.113583}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings